ResMed | RMD - 贷款资金

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 32.61B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	贷款资金	更改		日
Ansell	USD 751.6M		113.1M	2025-12
Artivion	USD 363.42M		148.07M	2026-06
AtriCure	USD 61M		0	2026-06
Baxter International	USD 8.62B		6M	2026-06
Cochlear	AUD 200M		6.5M	2025-12
Cooper Companies	USD 1.86B		17.7M	2026-03
CSL	USD 10.42B		273M	2025-12
Dexcom	USD 1.3B		200K	2026-06
Edwards Lifesciences	USD 598.7M		1.3M	2026-06
Fisher Paykel Healthcare	NZD 113.3M		50.7M	2026-06
Globus Medical	USD 398K		38K	2026-03
Haemonetics	USD 1.17B		50.36M	2026-06
Idexx Laboratories	USD 299.86M		11K	2026-06
Inogen	USD 0		0	2022-06
Insulet	USD 929.5M		0	2026-06
Integra LifeSciences	USD 1.83B		2.05M	2026-06
Intuitive Surgical	USD 0		0	2025-03
Medtronic	USD 27.88B		255M	2025-12
Philips	EUR 6.32B		575M	2026-06
Ramsay Health Care	AUD 11.2B		5.74B	2025-12
ResMed	USD 399.42M		4.75M	2026-06
Sigma Healthcare	AUD 1.88B		1.75B	2025-12
Sonic Healthcare	AUD 4.19B		333.39M	2024-12
Steris	USD 1.65B		162.6M	2026-06
Teleflex	USD 2.72B		206.24M	2026-06
Thermo Fisher Scientific	USD 39.18B		890M	2026-06